Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs
Science Advances · 2024
DOI: 10.1126/sciadv.adl4573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Inbar Fischer und 21 weiteren Autor:innen. Beteiligte Einrichtung: The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Nerve Tissue Proteins, Oligodendroglia, Disease Models, Animal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is characterized by social and neurocognitive impairments, with mutations of the SHANK3 gene being prominent in patients with monogenic ASD. Using the InsG3680 mouse model with a Shank3 mutation seen in humans, we revealed an unknown role for Shank3 in postsynaptic oligodendrocyte (OL) features, similar to its role in neurons. This was shown by impaired molecular and physiological glutamatergic traits of InsG3680-derived primary OL cultures. In vivo, InsG3680 mice exhibit significant reductions in the expression of key myelination–related transcripts and proteins, along with deficits in myelin ultrastructure, white matter, axonal conductivity, and motor skills. Last, we observed significant impairments, with clinical relevance, in induced pluripotent stem cell–derived OLs from a patient with the InsG3680 mutation. Together, our study provides insight into Shank3’s role in OLs and reveals a mechanism of the crucial connection of myelination to ASD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
- The School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
- The School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
- Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
- Department of Biomedicine-Experimental Biology Unit, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.
ORCID-Profile: Inbar Fischer, Yael Leichtmann-Bardoogo, Aviram Shemen, Utkarsh Tripathi, May Rokach, Yara Hussein, Ana Carolina Castro, Avi Schroeder, Patricia Monteiro, Shani Stern, Ben M Maoz, Boaz Barak
Zitieren
APA
Fischer, I., Shohat, S., Leichtmann-Bardoogo, Y., Nayak, R., Wiener, G., Rosh, I., Shemen, A., Tripathi, U., Rokach, M., Bar, E., Hussein, Y., Castro, A. C., Chen, G., Soffer, A., Schokoroy-Trangle, S., Elad-Sfadia, G., Assaf, Y., Schroeder, A., Monteiro, P., …, & Barak, B. (2024). Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs. Science Advances. https://doi.org/10.1126/sciadv.adl4573
Vancouver
Fischer I, Shohat S, Leichtmann-Bardoogo Y, Nayak R, Wiener G, Rosh I, et al. Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs. Science Advances. 2024. doi:10.1126/sciadv.adl4573
BibTeX
@article{Fischer2024,
author = {Fischer, Inbar and Shohat, Sophie and Leichtmann-Bardoogo, Yael and Nayak, Ritu and Wiener, Gal and Rosh, Idan and Shemen, Aviram and Tripathi, Utkarsh and Rokach, May and Bar, Ela and Hussein, Yara and Castro, Ana Carolina and Chen, Gal and Soffer, Adi and Schokoroy-Trangle, Sari and Elad-Sfadia, Galit and Assaf, Yaniv and Schroeder, Avi and Monteiro, Patricia and Stern, Shani and Maoz, Ben M and Barak, Boaz},
title = {Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adl4573}
}
EUVIMED